ERSGX | VSGAX | ERSGX / VSGAX | |
Total Expense Ratio | 1.46 | 0.07 | 2,086% |
Annual Report Gross Expense Ratio | 1.61 | 0.07 | 2,300% |
Fund Existence | 16 years | 14 years | - |
Gain YTD | -0.208 | 6.241 | -3% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 180M | 38.6B | 0% |
Annual Yield % from dividends | 0.09 | 0.51 | 18% |
Returns for 1 year | 1.50 | 18.22 | 8% |
Returns for 3 years | 19.94 | 42.63 | 47% |
Returns for 5 years | 23.01 | 42.21 | 55% |
Returns for 10 years | 1.43 | 141.95 | 1% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 140.36 | 2.87 | +2.09% |
Franklin Biotechnology Discovery A | |||
IGFRX | 24.53 | 0.15 | +0.62% |
Invesco EQV International Equity R6 | |||
PGJAX | 17.90 | 0.05 | +0.28% |
PGIM Jennison Global Infrastructure A | |||
ANFVX | 15.95 | 0.04 | +0.25% |
Virtus NFJ Small-Cap Value R6 | |||
OMGNX | 62.17 | -0.24 | -0.38% |
Invesco Main Street R |